Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and nine months ended 31st December, 2023 In continuation of our letter dated 22-Jan-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended https://www.torrentpharma.com/pdf/investors/TorrentPharma_Earnings_Q3_2023_24.pdf Kindly take note of the above.

Thanking you,

Intelligence (1)

No citations in view. Scroll through the transcript to see them here.

All Citations (1)

No citations in view. Scroll through the transcript to see them here.

TORNTPHARMCompany Page →